Home - Joint Venture

Joint Venture is a community of innovators, entrepreneurs, researchers, investors and others interested in driving innovation and entrepreneurship within musculoskeletal (MSK) health, hosted by Orthopaedic Research UK.

Through regular events, educational activities, policy work and investments, Joint Venture provides a forum for debate, acts as a force for positive change (especially in tackling systemic barriers to innovation) and supports entrepreneurs.

Joint Venture provides:

A forum for debate with regular on and off-line meetings
A force for positive change, especially in tackling systemic barriers to innovation
Access for early-stage MSK start-ups to potential investment, mentoring, education and networking support
A dynamic and supportive network

The aim of Joint Venture is to encourage innovation and entrepreneurialism within musculoskeletal health in the UK. This means:

MSK researchers aspiring to commercialise their work

MSK companies being able to scale their businesses in the UK

MSK spinouts from our universities

Innovative MSK companies bringing products and services to market

Our next event

Joint Venture is a forum for debate, with regular on and off-line meetings plus training events.

Event

MSK Innovation in the Workplace
Royal Society of Medicine

Date & Time

13 October 2026, 8:45am

View all

What you get from being part of Joint Venture

Investment

The opportunity to pitch for ORUK funding, plus access to angels, VCs, and other investors.

Academy

Developing entrepreneurial skills

Networking

Building valuable connections through regular face-to-face events and webinars.

Joint Venture has been a great way to get to know a whole community of MSK innovators in the UK. There’s a great mix of people, experience and skills and we have learned lots about UK innovation, how people do it and where we can make it better.

Professor Andy Metcalfe, Chief Medical Officer, Founder & Director, VerIQ

It is encouraging to see organisations like Joint Venture actively driving conversations, collaboration and practical change to better support innovators, researchers and patients.

Iva Hauptmannova, Director, Research Untangled

Equity support from ORUK has been very valuable to a young company like Renovos, because ORUK support, in addition to vital cash, provides external validation from a well-respected, specialist organisation as well as access to new contacts and networks.

James Otter, Chairman, Renovos

Joint Venture highlights a range of highly relevant topic and has been a great forum for advancing business development activities.

Joe Dupere, Chief Executive Officer, VerIQ

Championing innovation and entrepreneurship in MSK health in the UK

start ups funded by ORUK

£927k

invested by ORUK in early-stage MSK businesses

189

active innovative MSK companies in UK

£580m

equity funding raised by innovative MSK companies (2015-25)

innovative MSK spinouts

Latest News

Sponsoring Early-Stage Investment Summit

We’re delighted to be sponsoring The Early-Stage Investment Summit 2026, taking place in London on 23 November. The…

New sponsor for Joint Venture Academy

We are delighted to welcome TIME Interconnect MedTech UK Ltd as a sponsor of the Joint Venture Academy,…

New centre to accelerate innovation in surgical robotics

Imperial College London and the global medical technology company Smith+Nephew have launched the five-year partnership to deliver advances in robotic…

Join the Joint Venture network

Membership of Joint Venture is open to innovators, entrepreneurs, researchers, investors and others interested in driving innovation and entrepreneurship within musculoskeletal health. Membership is free and allows access to exclusive resources, plus advance notice of funding opportunities and events.

Join today

Joint Venture is hosted by Orthopaedic Research UK (ORUK) which is one of most significant funders of MSK research and innovation in the UK.

Learn more >